BMC infectious diseases
A randomized, non-inferiority phase III clinical trial of immunogenicity and safety of 5-dose and 4-dose schedules of a freeze-dried human rabies vaccine (MRC-5 cells) in participants aged 10-60.
Danhua Zhao, Junshi Zhao, Xiaopan Chen, Lingfeng Yuan, Ping Wang, Leitai Shi, Yunpeng Wang, Jia Li, Lijuan Zhou, Xiaohong Wu, Shilong Yang, Lidong Gao
Published: 202510.1186/s12879-025-12075-y
No abstract available for this study.